By Ludwig Burger and Maggie Fick FRANKFURT (Reuters) - Supplies of Novo Nordisk's popular weight-loss drug Wegovy are limited in Germany less than a m.
Supplies of Novo Nordisk's popular weight-loss drug Wegovy are limited in Germany less than a month after its launch in Europe's largest drug market, major drug distributors and doctors told Reuters. The volumes of the weekly injection that the Danish drugmaker has delivered to the country so far have fallen short of strong demand, the wholesalers said. "Demand is by far exceeding the available volumes," a spokesperson for Noweda, which has almost a quarter of the German drug wholesale trade, told Reuters, adding the problem was nationwide.
Frustrated after
countless failed diet and exercise attempts, 41 year-old Jessica
Lenth from Hamburg has started putting money aside for a drug
that she sees as a possible door to a life without.
FRANKFURT/LONDON - Frustrated after countless failed diet and exercise attempts, 41-year-old Jessica Lenth from Hamburg has started putting money aside for a drug that she sees as a possible door to a life without obesity. Interviews with seven doctors and two other potential users of Wegovy from Germany, where Novo Nordisk's weight-loss drug will become available at the end of.